Concepedia

Dongwen Wang

DW

Statistics

Publications

30

Citations

1.3K

H-Index

17

Active since

2004

Affiliations

Shanxi Medical University(Current)

First Hospital of Shanxi Medical University

Chinese Academy of Medical Sciences & Peking Union Medical College

Peking University

Changhai Hospital

Dongwen Wang is an author at Shanxi Medical University specializing in medicine, oncology, and prostate cancer.

ORCID

Publications per year

2004–2024

30

Publications

30

Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment.

Larion Santiago, Garrett Daniels, Dongwen Wang et al. · PubMed · 2017 · 213 citations

, , +17

Prostate cancer in Asia: A collaborative report

Rui Chen, Shancheng Ren, Ming Kwong Yiu et al. · Asian journal of urology · 2014 · 210 citations · Full text

, , +17

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 141 citations · Full text

, , +17

The status and characteristics of urinary stone composition in China

Zhangqun Ye, Guohua Zeng, Huan Yang et al. · British Journal of Urology · 2019 · 134 citations · Full text

, , +13

Current status of diagnosis and treatment of bladder cancer in China – Analyses of Chinese Bladder Cancer Consortium database

Kaiwen Li, Tianxin Lin, Wei Xue et al. · Asian journal of urology · 2015 · 58 citations · Full text

, , +14

1–5 of 30